Zantac Recall Attorneys

Summary

Zantac is the brand name for the prescription and over the counter drug ranitidine, which began selling in 1982 and was heavily marketed to treat gastric issues such as acid reflux and ulcers. It was discovered that the drugs contained a carcinogenic substance called NDMA which is known to be toxic to humans and has been shown to cause various types of cancer. It was banned by the FDA in 2020 and since then, Zantac lawsuits and Zantac class action litigation are in the early stages. Turnbull, Holcomb & LeMoine are capable and experienced attorneys who can take Zantac mass tort cases such as these the full distance to a jury trial. Contact us now for a free consultation and evaluation of your case (888) 488-9616.

What is Zantac?

Zantac is the brand-name for the drug ranitidine, which is an acid reducer used to treat heartburn, acid indigestion, GERD (Gastroesophageal Reflux Disease) and gastric ulcers. Ranitidine was first created in England in 1977 under the research laboratories of what was then Glaxo and became GlaxoSmithKline Corporation following several mergers and acquisitions. Ranitidine was introduced into the market in 1981 and was eventually the highest selling worldwide prescription drug by 1987. Zantac was a heavily marketed drug over the years until its recall, and it was very common to see a Zantac commercial featuring cartoon firemen characters putting out the “flames” of acid reflux. Zantac and ranitidine were available both by prescription and over the counter and were consumed by millions of people until it was taken off the market starting in 2019.

Why Is Zantac Dangerous?

Zantac and ranitidine were found to contain an impurity which is a known human carcinogen called N-nitrosodimethylamine (NDMA). Studies of NDMA have shown that there is sufficient evidence of a causal relationship between the chemical and cancer in humans. Although NDMA is a carcinogen that is found in small amounts in processed foods such as beer, fish, cured meats such as bacon, cheese and even vegetables, it is normally processed by the liver and is expelled from the body via exhaled air or urine. The problem with Zantac and ranitidine is that the amounts of NDMA are so high and the exposure so regular that it becomes toxic to the body and the toxicity to the body can cause adverse effects because the body cannot break down the toxins at that high concentration. Not only did the drugs contain large amounts of NDMA at the time of manufacture but it was discovered that the longer the drugs sat on the shelf for sale that the molecular structures of ranitidine actually broke down into higher concentrations of NDMA because the molecules were unstable.

What Are The Diseases Linked To Zantac?

Studies and revelations about victims who have taken Zantac, often in large quantities and/or for large periods of time, have shown that many people have developed a wide variety of cancer. In figuring out the link between Zantac and victims who developed cancer it was found that a large portion of those who were tested had no family history or genetic markers for cancer, and after speculation about an environmental or external influence that was causing these cancers, it was discovered that many had the commonality of having taken Zantac and/or ranitidine. The research and subsequent fallout from what we now know about these drugs, we believe that the following types of cancers are very likely linked to the use of Zantac and ranitidine: Liver cancer, Melanoma, Ovarian cancer, Colon Cancer, Breast cancer, Bladder cancer, Kidney cancer, Esophageal cancer, Stomach cancer, Prostate cancer. There are also some other health conditions that are believed to have a link to Zantac, such as Primary Pulmonary Hypertension (PPH) and Crohn’s Disease.

When Was Zantac Recalled?

On September 13, 2019, the Food and Drug Administration (FDA) issued a public warning which stated that Zantac contained unacceptable levels of NDMA. Immediately after the warning was issued, several of the major retailers such as CVS, Walgreens, Walmart, and Rite-Aid who were filling prescriptions for and selling Zantac on the shelves began pulling the product off the shelves and out of their pharmacies. In April of 2020, the FDA told all manufacturers to stop selling Zantac, because of the revelation that NDMA contamination can increase over time. It has been a relatively short period of time that has passed since the recall and now lawsuits and litigation have begun to appear in significantly higher numbers due to the high number of victims that have been affected.

What Is The Basis For Zantac Lawsuits?

Victims and the attorneys representing them are claiming that the manufacturers knew the drug contained the carcinogenic chemical NDMA, in addition to the fact that Zantac was a defective drug because its instability caused the amount of NDMA to increase over time. The marketing and labels on the drug never mentioned any warning about the potential for cancer by using the drug. After the expiration of the patent on Zantac by Glaxo corporation, led to the drug being manufactured and prescribed or sold by several other companies. Possible defendants in these cases include GlaxoSmithKline, Sanofi-Aventis US, LLC, Sanofi US Services, Inc., Chattem, Inc., Pfizer and Boehringer Ingelheim. Litigation for the victims being represented in these cases is still in the early stages, and the earliest trials may occur in 2022. Currently, the Southern District of Florida has been designated as the court for a Multi-District Litigation housing hundreds of lawsuits that are pending.

Zantac Class Actions, Settlements, And Lawsuits

Zantac class action lawsuits are in the midst of being proposed by attorneys representing victims in California, Connecticut, Florida, New Jersey, and Massachusetts. These proposed class actions are intended for those victims who purchased and used Zantac or ranitidine but do not have a cancer diagnosis. The victims must only prove that they purchased the drug and did not receive a warning about the cancer risk. These Zantac class action lawsuits are simply intended to refund the purchase price of Zantac to the victims and are not offering any compensation to them for cancer. As of November 3, 2021 there have been no Zantac settlements, or trial verdicts as a result of the ongoing litigation. It is expected that settlements will happen in the future, and these cases will start appearing in front of juries that will pursue justice for the victims, however, no timeline for this has yet been established.

Turnbull, Holcomb & LeMoine Zantac Lawsuits

Litigation and a trial of a lawsuit of this scope and nature is a monumental task. A Zantac lawsuit has the potential to involve many defendants, untold millions of pages of disclosure, dozens of depositions and easily thousands of hours of preparation for the ultimate goal of justice for the person affected by the negligence of these manufacturers and their indifference to safety. Turnbull, Holcomb & LeMoine have the resources, expertise, and experience to try this type of case and bring a successful outcome, one which not only compensates the victims but includes punitive damages for the failures of the pharmaceutical companies who must be held accountable for their negligence and indifference to the victims. Whether you are an attorney currently representing a victim of Zantac or a person or family member of someone directly affected, you can end your search for representation here and trust Turnbull, Holcomb & LeMoine to not only litigate your case, but carry it all the way to trial for the best possible outcome.

Our Qualifications

At Turnbull, Holcomb & LeMoine, we are recognized as a national law firm and are licensed in over 25 states. Our reputation speaks for itself, and we are known for our enduring resolve to take cases to trial that other attorneys simply did not have the capabilities and resources for. With over (x number??) of trials with successful outcomes and regular trial awards exceeding our clients’ expectations, we regularly push the bar higher in our efforts to bring justice to plaintiffs who need the best representation at trial. Preparation is the name of the game when we appear in the courtroom at trial. We focus on strategic structuring of trial arguments, in-depth witness preparation, comprehensive jury research, case strategies built through focus groups and mock trials and have a reputation for winning against deep pocketed corporations. We offer regular communication and case updates to parties of interest, competitive fee agreements and are committed to maximizing results. (Any other statistics here?)

What’s next? (Need advice here, don’t see a class action for paraquat in my research)

If you are an attorney who is currently representing a client who wants to further litigate their claim against a Zantac manufacturer and take it to trial, then you are in the right place. If your client has decided to opt-out of a class action settlement, your search ends here. Simply call us at (888) 488-9616 or use the contact form on our website to schedule a free and confidential consultation with a highly qualified trial attorney to discuss how we can help and take your case to the next level.